GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,462,000 | +264.6% | 12,672 | +207.1% | 0.00% | +100.0% |
| Q3 2020 | $401,000 | +3241.7% | 4,127 | +4027.0% | 0.00% | – |
| Q2 2020 | $12,000 | -96.4% | 100 | -97.3% | 0.00% | -100.0% |
| Q1 2020 | $330,000 | -57.8% | 3,772 | -49.6% | 0.00% | -50.0% |
| Q4 2019 | $782,000 | -52.4% | 7,484 | -47.7% | 0.00% | -60.0% |
| Q3 2019 | $1,644,000 | +423.6% | 14,300 | +666.3% | 0.01% | +400.0% |
| Q1 2019 | $314,000 | -14.0% | 1,866 | -50.3% | 0.00% | 0.0% |
| Q4 2018 | $365,000 | -91.3% | 3,756 | -84.5% | 0.00% | -92.3% |
| Q3 2018 | $4,196,000 | +201.9% | 24,291 | +143.8% | 0.01% | +160.0% |
| Q2 2018 | $1,390,000 | +13.0% | 9,965 | +6.9% | 0.01% | -90.6% |
| Q4 2017 | $1,230,000 | -4.2% | 9,324 | -26.3% | 0.05% | +1.9% |
| Q3 2017 | $1,284,000 | +110.8% | 12,659 | +132.0% | 0.05% | +44.4% |
| Q4 2016 | $609,000 | +21.1% | 5,456 | -0.7% | 0.04% | +5.9% |
| Q2 2016 | $503,000 | +570.7% | 5,494 | +403.1% | 0.03% | +466.7% |
| Q4 2015 | $75,000 | -77.1% | 1,092 | -69.6% | 0.01% | -84.2% |
| Q1 2015 | $327,000 | – | 3,589 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|